GSK expected to launch COVID vaccine with Sanofi at the end of this year
Updated: 2021-07-30
Pfizer on Wednesday raised its sales forecast for its COVID-19 vaccine by almost a third to $33.5bn this year. Its counterpart GSK is hoping to launch its COVID-19 vaccine at the end of this year with Sanofi.
